Publicaciones en colaboración con investigadores/as de University of Pennsylvania (12)

2024

  1. CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

    Cancer Letters, Vol. 588

2021

  1. NAC blocks Cystatin C amyloid complex aggregation in a cell system and in skin of HCCAA patients

    Nature Communications, Vol. 12, Núm. 1

2019

  1. ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor

    Nature Medicine, Vol. 25, Núm. 7, pp. 1116-1122

  2. RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation

    Leukemia, Vol. 33, Núm. 8, pp. 2006-2021

2018

  1. Pathogenic variant in EPHB4 results in central conducting lymphatic anomaly

    Human Molecular Genetics, Vol. 27, Núm. 18, pp. 3233-3245

2016

  1. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38α activation, while it impairs tumor growth through p38α-independent mechanisms

    Oncotarget, Vol. 7, Núm. 29, pp. 45060-45078

2015

  1. PKCε is an essential mediator of prostate cancer bone metastasis

    Molecular Cancer Research, Vol. 13, Núm. 9, pp. 1336-1346

  2. p38 MAPK down-regulates fibulin 3 expression through methylation of gene regulatory sequences: Role in migration and invasion

    Journal of Biological Chemistry, Vol. 290, Núm. 7, pp. 4383-4397

2014

  1. Transcriptional regulation of oncogenic protein kinase Cε (PKCε) by STAT1 and Sp1 proteins

    Journal of Biological Chemistry, Vol. 289, Núm. 28, pp. 19823-19838

  2. β3-Chimaerin, a novel member of the chimaerin Rac-GAP family

    Molecular Biology Reports, Vol. 41, Núm. 4, pp. 2067-2076

2013

  1. Coordinated activation of the Rac-GAP β2-chimaerin by an atypical proline-rich domain and diacylglycerol

    Nature Communications, Vol. 4

2012

  1. Rac signaling in breast cancer: A tale of GEFs and GAPs

    Cellular Signalling, Vol. 24, Núm. 2, pp. 353-362